Robert T. Kavitt, M.D.
Dr. Kavitt is currently a resident in the Department of Medicine at the University of Chicago Hospitals. He graduated from Brandeis University in 2002 with a B.A. in Biology, having graduated magna cum laude and Phi Beta Kappa. He attended medical school at the University of Chicago Pritzker School of Medicine, and earned his M.D. in June 2006.
He has worked with the Rubin Group since the spring of 2003. He is particularly interested in the genetics of inflammatory bowel disease and colorectal cancer prevention, as well as the role of wireless capsule endoscopy.
He has worked on a number of projects with the Rubin Group, including "Why Do Colorectal Cancer Patients Have Inaccurate Perceptions of the Risk to their First Degree Relatives? A Pilot Study to Explore Differences between African-American and Caucasian Populations" and "A look at the impact of anxiety, depression, and other factors on inflammatory bowel disease patients' interest in genetic testing for IBD". He is currently working on a study assessing the use of genetic testing for IBD among a patient family, as well as a multicenter trial looking at the use of rifaximin in the treatment of clostridium difficile infection.
Recent publications include the following:
He has worked with the Rubin Group since the spring of 2003. He is particularly interested in the genetics of inflammatory bowel disease and colorectal cancer prevention, as well as the role of wireless capsule endoscopy.
He has worked on a number of projects with the Rubin Group, including "Why Do Colorectal Cancer Patients Have Inaccurate Perceptions of the Risk to their First Degree Relatives? A Pilot Study to Explore Differences between African-American and Caucasian Populations" and "A look at the impact of anxiety, depression, and other factors on inflammatory bowel disease patients' interest in genetic testing for IBD". He is currently working on a study assessing the use of genetic testing for IBD among a patient family, as well as a multicenter trial looking at the use of rifaximin in the treatment of clostridium difficile infection.
Recent publications include the following:
- Rubin D.T., Kavitt R.T. Surveillance for Cancer and Dysplasia in Inflammatory Bowel Disease. Gastroenterology Clinics of North America. 2006 Sep; 35(3): 581-604.
- Kavitt R., Neher J. Does long-term use of inhaled corticosteroids affect the growth of asthmatic children? Evidence-Based Practice. 2006 Feb; 9(2): 6-7.
